Genetic cancer gene screening - a "road map" for the future of health
Hereditary cancer screening is a method that uses gene sequencing technology to detect mutations that can increase the risk of cancer.
Some studies have shown that about 5-10% of cancer cases are related to genetic factors. A person carrying a hereditary cancer gene mutation may not show obvious symptoms for many years, but the risk of developing cancer is higher than that of a person without the mutation.
In particular, cancers such as breast, ovarian, colorectal, pancreatic, and thyroid cancers are often noted to have a clear genetic nature.
Cancer genetic screening provides important health information.
MSc.BSNT Nguyen Ba Son - Head of Genetics Department, MEDLATEC Testing Center, said the specific significance of screening for hereditary cancer genes:
- Predicting individual risk of hereditary cancers.
- Support doctors in developing monitoring, screening and early intervention plans, before the disease manifests.
- Provide information to family members about genetic risks.
- Optimize treatment and prevention options for people carrying gene mutations.
Who should have hereditary cancer screening?
Everyone can screen for cancer-causing genes to proactively control their health, understand the risks to prevent timely. However, some of the following groups of people are at high risk and should consider doing it early, including:
- People with a family history of cancer.
- Women with relatives who have had breast, ovarian, or endometrial cancer, especially if related to the BRCA1 or BRCA2 genes.
- People of high genetic risk ethnicity (Ashkenazi Jews).
- People who have had a type of cancer.
- Parents with young children want to assess the risk of genetic cancer early, in order to develop an appropriate screening plan.
Oncosure Plus Test - Decoding 145 cancer risk gene mutations
In the genetic testing portfolio, the Oncosure Plus test is one of the most comprehensive and advanced methods, helping to screen for 30 types of hereditary cancers.
Oncosure Plus is a test that uses Next Generation Sequencing (NGS) technology to analyze 145 gene mutations that have been studied to be associated with hereditary cancers.
Thanks to its accuracy and wide coverage, this test can assess the risk of cancers such as: breast, ovarian, endometrial, skin, colon - rectum, paraganglioma, kidney, stomach, retinoblastoma, pancreas, prostate, bladder, lung, thyroid, pheochromocytoma, multiple myeloma, parathyroid, multiple endocrine neoplasia, neurofibroma, head - neck, bone, pituitary, liver, brain, rhabdomyosarcoma, neuroblastoma, acute leukemia, biliary tract, small intestine, esophagus.
After the blood sample is collected and sent to the Laboratory for analysis, the results will be returned within 15 working days from the date of receipt of the sample (excluding Saturdays, Sundays and holidays). The results are consulted by a team of experts and leading genetic doctors.
Currently, the Oncosure Plus test is deployed at MEDLATEC Healthcare System, a unit applying modern gene sequencing technology in Vietnam. This is one of the first medical facilities to simultaneously possess two international quality management certificates, CAP (USA) and ISO 15189:2022 - ensuring the accuracy, safety and reliability of the results.
MEDLATEC testing center owns a modern, high-tech machine system.
Many offers for genetic screening
On the occasion of Vietnamese Family Day (June 28), MEDLATEC Healthcare System is launching a special promotion program - giving away 2 million VND when registering for 1 of 3 cancer screening genetic tests (SPOT-MAS, SPOT-MAS 10, Oncosure Plus).
To receive the offer, customers must register from now until June 30, applicable at hospitals, clinics, or on-site sample collection services nationwide.
MEDLATEC offers attractive incentives when registering for genetic cancer screening testing.
For detailed information about the 3 genetic tests, please refer here.
From now until June 30, MEDLATEC is launching a big promotion program, offering a series of health gifts worth millions of dong, details as follows:
Get 2 million VND when registering for 1 of 3 cancer screening genetic tests (SPOT-MAS, SPOT-MAS 10, Oncosure Plus).
Get 1 million VND when registering for a comprehensive health check-up package at home - check 38 health categories and find cancer markers for women.
15% off regular health check-ups at home.
Free colorectal cancer screening test (CEA) and examination with a specialist.
In addition, from now until July 30, MEDLATEC offers attractive promotions to protect a healthy liver:
- Free AST, ALT testing.
- Free abdominal ultrasound.
Contact hotline 1900 56 56 56 to register to receive incentives, or customers register here.
Source: https://dantri.com.vn/suc-khoe/tam-soat-gen-giup-phat-hien-som-nguy-co-ung-thu-di-truyen-20250628204043253.htm
Comment (0)